Provided by Tiger Fintech (Singapore) Pte. Ltd.

Edgewise Therapeutics, Inc.

14.30
-0.5500-3.70%
Post-market: 14.300.00000.00%16:10 EDT
Volume:485.38K
Turnover:6.98M
Market Cap:1.51B
PE:-9.22
High:14.86
Open:14.86
Low:14.21
Close:14.85
52wk High:38.12
52wk Low:10.60
Shares:105.35M
Float Shares:60.53M
Volume Ratio:0.82
T/O Rate:0.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5508
EPS(LYR):-1.4480
ROE:-27.41%
ROA:-19.06%
PB:2.56
PE(LYR):-9.88

Loading ...

Edgewise Therapeutics Inc. Chief Scientific Officer Russell Alan J Reports Disposal of Common Shares

Reuters
·
May 08

John R. Moore, General Counsel, Reports Disposal of Edgewise Therapeutics Inc. Common Shares

Reuters
·
May 08

Why Edgewise Therapeutics Stock Popped This Week

Motley Fool
·
May 03

Guggenheim Starts Edgewise Therapeutics With Buy Rating, $41 Price Target

MT Newswires Live
·
Apr 30

Guggenheim starts Edgewise with Buy on ‘compelling entry point’

TIPRANKS
·
Apr 30

Biotech Stock Roundup: PCRX Up on Patent News, EWTX Down on Study Data & More

Zacks
·
Apr 10

Edgewise Therapeutics (EWTX): Among Unstoppable Stocks That Could Double Your Money

Insider Monkey
·
Apr 06

Major Stake Acquisitions Signal Confidence in Edgewise Therapeutics

TIPRANKS
·
Apr 05

Edgewise Therapeutics Downgraded Following Safety Issues in Heart Drug Trial

GuruFocus.com
·
Apr 04

Edgewise Therapeutics Says Believes Atrial Fibrillation Not Driven by EDG-7500 in Phase 2 Trial, RBC Says

MT Newswires Live
·
Apr 04

Edgewise Therapeutics Cut to Sector Perform From Sector Outperform by Scotiabank

Dow Jones
·
Apr 03

RBC Lowers Price Target on Edgewise Therapeutics to $52 From $56, Keeps Outperform, Speculative Risk

MT Newswires Live
·
Apr 03

U.S. RESEARCH ROUNDUP-Alphabet, Amazon, Meta

Reuters
·
Apr 03

Edgewise Therapeutics Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Apr 03

BUZZ-U.S. STOCKS ON THE MOVE-M-tron, Rocket Companies, TKO Group

Reuters
·
Apr 03

BUZZ-Edgewise falls on safety, efficacy doubts for heart disease drug

Reuters
·
Apr 02

Edgewise Therapeutics 9.935M share Spot Secondary priced at $20.13

TIPRANKS
·
Apr 02

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Wednesday Ahead of US Tariffs Announcement

MT Newswires Live
·
Apr 02

Morning Brew: Folksam Divests Tesla Amid Labor Concerns

GuruFocus
·
Apr 02

Edgewise Therapeutics Shares Tumble on Underwritten Public Offering Pricing

Dow Jones
·
Apr 02